Synbiotics, prebiotics and probiotics for people with chronic kidney disease
Tess E Cooper(The University of Sydney), Germaine Wong(Children's Hospital at Westmead), David W. Johnson(Hennepin County), Armando Teixeira‐Pinto(The University of Sydney), Martin Howell(UNSW Sydney), Carmel M. Hawley(The University of Queensland), Samuel Chan(Princess Alexandra Hospital), Rabia Khalid(The University of Sydney), Allison Jauré(The University of Sydney), Jonathan C. Craig(Flinders University)
Cited by 47
Related Papers
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
|The Lancet|2017|923
Chronic Kidney Disease and Coronary Artery Disease
|Journal of the American College of Cardiology|2019|716
Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis
|The Lancet|2015|394
Chronic kidney disease and arrhythmias: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
|European Heart Journal|2018|285
A practical guide to multiple imputation of missing data in nephrology
|Kidney International|2020|282